
| OPPONENT | AB | R | H | 1B | 2B | 3B | HR | BB | RBI | SO | SAC | SB | AVG | SLG | OB | OPS | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mondelez | 2 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | .000 | .000 | .333 | .333 | |
| ASCO | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | .000 | .000 | .000 | .000 | |
| Novartis #2 | 3 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | .333 | .333 | .333 | .667 | |
| Evonik | 3 | 1 | 3 | 3 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1.000 | 1.000 | 1.000 | 2.000 | |
| Celgene #2 | 3 | 0 | 1 | 1 | 0 | 0 | 0 | 2 | 1 | 0 | 0 | 0 | .333 | .333 | .600 | .933 | |
| TOTAL | 14 | 2 | 5 | 5 | 0 | 0 | 0 | 3 | 4 | 2 | 0 | 0 | .357 | .357 | .471 | .828 |